Masato Tamate1, Ryoichi Tanaka2, Hiroyuki Osogami2, Motoki Matsuura2, Seiro Satohisa2, Masahiro Iwasaki2, Tsuyoshi Saito2. 1. Department of Obstetrics and Gynecology, Sapporo Medical University Hospital, South1 West16, Chuo-ku, Sapporo, Hokkaido, Japan. Electronic address: mtamate@sapmed.ac.jp. 2. Department of Obstetrics and Gynecology, Sapporo Medical University Hospital, South1 West16, Chuo-ku, Sapporo, Hokkaido, Japan.
Abstract
OBJECTIVE: Endometrioid adenocarcinoma (EAC) is a common endometrial cancer with recent dramatic increases in incidence. Previous findings indicate that Rap1GAP acts as a tumor suppressor inhibiting Ras superfamily protein Rap1 in multiple aggressive carcinomas; however, Rap1GAP expression in EAC has not been investigated. In this study, the tumor suppressing activity of Rap1GAP in EAC was explored. METHODS: EAC cell lines were used to examine Rap1GAP levels by real-time RT-PCR and western blotting and the effects of Rap1GAP on cancer cell invasion and migration. Rap1GAP expression was analyzed by immunohistochemical staining for Rap1GAP, E-cadherin in surgically resected tumors of 114 EAC patients scored according to EAC differentiation grade. Prognostic variables such as age, stage, grade, tumor size, and immunostaining for Rap1GAP, E-cadherin were evaluated using Cox regression multivariate analysis. RESULTS: Low Rap1GAP expression was detected in poorly differentiated EAC cells. Rap1GAP deficiency significantly accelerated while Rap1 deficiency decreased cancer cell migration and invasion. Patients with higher Rap1GAP, E-cadherin, and especially combined Rap1GAP/E-cadherin levels had better overall survival than EAC patients with no or weak expression. In addition, Rap1GAP expression was an independent prognostic factor in EAC. CONCLUSIONS: Inhibition of Rap1GAP expression increases EAC cell migration and invasion through upregulation of Rap1. Low expression of Rap1GAP correlates with poor EAC differentiation. Our findings suggest that Rap1GAP is an important tumor suppressor with high prognostic value in EAC.
OBJECTIVE:Endometrioid adenocarcinoma (EAC) is a common endometrial cancer with recent dramatic increases in incidence. Previous findings indicate that Rap1GAP acts as a tumor suppressor inhibiting Ras superfamily protein Rap1 in multiple aggressive carcinomas; however, Rap1GAP expression in EAC has not been investigated. In this study, the tumor suppressing activity of Rap1GAP in EAC was explored. METHODS: EAC cell lines were used to examine Rap1GAP levels by real-time RT-PCR and western blotting and the effects of Rap1GAP on cancer cell invasion and migration. Rap1GAP expression was analyzed by immunohistochemical staining for Rap1GAP, E-cadherin in surgically resected tumors of 114 EAC patients scored according to EAC differentiation grade. Prognostic variables such as age, stage, grade, tumor size, and immunostaining for Rap1GAP, E-cadherin were evaluated using Cox regression multivariate analysis. RESULTS: Low Rap1GAP expression was detected in poorly differentiated EAC cells. Rap1GAP deficiency significantly accelerated while Rap1deficiency decreased cancer cell migration and invasion. Patients with higher Rap1GAP, E-cadherin, and especially combined Rap1GAP/E-cadherin levels had better overall survival than EAC patients with no or weak expression. In addition, Rap1GAP expression was an independent prognostic factor in EAC. CONCLUSIONS: Inhibition of Rap1GAP expression increases EAC cell migration and invasion through upregulation of Rap1. Low expression of Rap1GAP correlates with poor EAC differentiation. Our findings suggest that Rap1GAP is an important tumor suppressor with high prognostic value in EAC.
Authors: Sangappa B Chadchan; Pooja Popli; Chandrasekhar R Ambati; Eric Tycksen; Sang Jun Han; Serdar E Bulun; Nagireddy Putluri; Scott W Biest; Ramakrishna Kommagani Journal: Life Sci Alliance Date: 2021-09-30
Authors: Zheng Yan; Wang Yangyanqiu; Han Shuwen; Mao Jing; Liao Haihong; Chen Gong; Jin Yin; Zhou Qing; Gao Weili Journal: Biomed Res Int Date: 2021-11-18 Impact factor: 3.411
Authors: Seema Shah; Ethan J Brock; Ryan M Jackson; Kyungmin Ji; Julie L Boerner; Bonnie F Sloane; Raymond R Mattingly Journal: Neoplasia Date: 2018-08-22 Impact factor: 5.715